Search results

Choosing the right CRO as a partner for your drug development programs is a vitally important step to achieving critical decision making early on for important milestones, and ultimately getting your molecule from discovery to market efficiently.

Artificial intelligence, or AI, has been on the radar screen as a possible tool to improve drug development, and clinical trial design and conduct for some time. This month's blog covers some of the advancements.

Adverse drug reactions caused by individual drugs and drug combinations contribute to one of the top 10 causes of death in the United States. This blog offers insight on minimizing the risks with DDI studies.

Does the CRO you’re working with have what it takes to successfully conduct First-in-Human (FIH) clinical research? What are FIH trials?It’s important to define what...

Springtime brings the sunshine, warmer temperatures and if you’re into such things, a big basketball tournament. You are probably familiar with the ...